NCT01364831

Brief Summary

In the last few decades much knowledge has been accumulated on the connection between healthy, sufficient sleep and overall health, cognitive function, memory and job or school performance, motor vehicle accidents and work accidents. There has been growing awareness recently of the connection between physical activity and competitive sports performance, and the amount and quality of sleep. Despite the dearth of scientific studies, there is a constant effort to improve understanding in this field. An appropriate procedure designed to evaluate the influence of the quality and amount of sleep on ability and athletic performance must fulfill a number of basic requirements:

  • Many studies show that shortened sleep duration constitutes an independent cause of increased cardiac events.
  • Resting heart rate and maximum heart rate decrease after 30 hours of sleep deprivation. Respiratory System:
  • Significant decline in respiratory function as measured by: FVC, Maximal voluntary ventilation, Maximal static inspiratory/expiratory pressures, Time to exhaustion with exercise, Peak O2 consumption, Peak CO2 production.
  • Worsening of respiratory sleep disturbances. Digestive System:
  • Changes in food consumption accompanied by changes in body weight. Neurophysiological System
  • Disturbance of thermoregulation. Endocrine System:
  • Hormonal changes associated with hypothalamic-hypophyseal axis
  • Influence on secretion of Ghrelin and leptin
  • Influence on secretion of growth hormone. In light of this, there is sound basis for the presumption that athletic performance is connected to these influences directly and indirectly. The purpose of this study is to evaluate the connection between sleep quality and duration and athletic performance among young athletes living and training at the Sport-Gifted Centre at the Wingate Institute.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 29, 2011

Completed
2 months until next milestone

Study Start

First participant enrolled

June 1, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 2, 2011

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2012

Completed
Last Updated

January 1, 2014

Status Verified

December 1, 2013

Enrollment Period

1.4 years

First QC Date

March 29, 2011

Last Update Submit

December 31, 2013

Conditions

Keywords

sleep timeathletic performance

Outcome Measures

Primary Outcomes (1)

  • Improved athletic performance: reduced swimming and running times over predefined distances with sleep extension

    Measure the changes in performance (running and swimmimng time) as follows: for runners- time required for 3000 m distance. for swimmers- time required for 50 m, 100 m, and 400 m, at predefined heart rates.

    12 months

Interventions

Sleep extensionBEHAVIORAL

Athletic performance evaluated at baseline and following about 1.5 hours of sleep extension

Eligibility Criteria

Age13 Years - 20 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age: 13-20 years old, male and female
  • Generally good health
  • Willingness to participate in the study
  • Healthy heart rate

You may not qualify if:

  • Arrhythmia
  • Chronic or acute illness
  • Unwillingness of the subject or his/her parents to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wingate Institute

Netanya, 42902, Israel

Location

Related Links

Study Officials

  • Eyal Shargal, PhD

    Wingate Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professional director , The Ribstein Center for Sports Medicine and Research

Study Record Dates

First Submitted

March 29, 2011

First Posted

June 2, 2011

Study Start

June 1, 2011

Primary Completion

November 1, 2012

Study Completion

November 1, 2012

Last Updated

January 1, 2014

Record last verified: 2013-12

Locations